Article
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells
15 May 2020
Abstract excerpt
CD19-directed CAR-T-cells (CD19-CAR) have demonstrated remarkable clinical results in patients suffering from refractory or relapsed lymphoma and acute lymphoblastic leukemia. In order to further optimize follow-up, to explain treatment failure, and to control adverse events biomarkers for monitoring of response are urgently needed. Peak expansion and persistence are correlated with response rates and severity of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
